Inventor · disambiguated record
David J. Morgans, Jr.
Also filed as: MORGANS DAVID · MORGANS DAVID J · MORGANS DAVID J JR · MORGANS JR DAVID
103 granted patents·41 pending applications·1,569 citations·filing 1988–2025
99Inventor score
Files withCYTOKINETICS INC56PLIANT THERAPEUTICS INC15SYNTEX INC13SMITHKLINE BEECHAM CORP12QIAN XIANGPING11
Top patents by PatentIndex Score
144 records- 0199US10975034B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2019·Granted Apr 13, 2021·23 cites·2 claims
- 0299US7507735B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2005·Granted Mar 24, 2009·72 cites·30 claims
- 0398US10385023B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2018·Granted Aug 20, 2019·23 cites·2 claims
- 0498US10035770B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2017·Granted Jul 31, 2018·25 cites·19 claims
- 0598US9643925B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2015·Granted May 9, 2017·26 cites·18 claims
- 0697US10696672B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Jun 30, 2020·21 cites·34 claims
- 0797US9150564B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2014·Granted Oct 6, 2015·28 cites·7 claims
- 0897US8871769B2Ureas and their use in the treatment of heart failureCYTOKINETICS INC·Filed 2013·Granted Oct 28, 2014·31 cites·1 claims
- 0997US8513257B2Ureas and their use in the treatment of heart failureMORGAN BRADLEY PAUL·Filed 2011·Granted Aug 20, 2013·30 cites·32 claims
- 1097US8110595B2Ureas and their use in the treatment of heart failureMORGAN BRADLEY PAUL·Filed 2005·Granted Feb 7, 2012·37 cites·34 claims
- 1197US7718657B2Certain indanyl urea modulators of the cardiac sarcomereCYTOKINETICS INC·Filed 2006·Granted May 18, 2010·20 cites·10 claims
- 1297US7538223B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2006·Granted May 26, 2009·26 cites·7 claims
- 1397US6753428B2Process for the racemization of chiral quinazolinonesCYTOKINETICS INC·Filed 2002·Granted Jun 22, 2004·57 cites·12 claims
- 1496US11634418B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Apr 25, 2023·5 cites·41 claims
- 1596US10793564B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2019·Granted Oct 6, 2020·25 cites·69 claims
- 1696US8101617B2Disubstituted ureas and uses thereof in treating heart failureMORGAN BRADLEY PAUL·Filed 2008·Granted Jan 24, 2012·28 cites·32 claims
- 1796US8101620B2Heterocyclic sulfonamidesMORGAN BRADLEY PAUL·Filed 2011·Granted Jan 24, 2012·40 cites·12 claims
- 1896US7888373B2Heterocyclic sulfonamides as modulators of cardiac sarcomeresCYTOKINETICS INC·Filed 2009·Granted Feb 15, 2011·40 cites·11 claims
- 1996US7041676B2Compounds, compositions, and methodsSMITHKLINE BEECHAM CORP·Filed 2003·Granted May 9, 2006·87 cites·37 claims
- 2095US11560376B2Amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jan 24, 2023·6 cites·79 claims
- 2195US10604520B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2017·Granted Mar 31, 2020·20 cites·52 claims
- 2295US8871768B2Certain chemical entities, compositions and methodsCYTOKINETICS INC·Filed 2013·Granted Oct 28, 2014·24 cites·12 claims
- 2394US11180494B2Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2019·Granted Nov 23, 2021·11 cites·47 claims
- 2493US12264133B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2021·Granted Apr 1, 2025·1 cites·15 claims
- 2593US8445495B2Certain Chemical entities, compositions and methodsMORGAN BRADLEY P·Filed 2009·Granted May 21, 2013·25 cites·2 claims
- 2693US7595322B2Heterocyclic sulfonamides as modulators of cardiac sarcomeresCYTOKINETICS INC·Filed 2004·Granted Sep 29, 2009·41 cites·10 claims
- 2793US7399866B2Compounds, compositions, and methodsCYTOKINETICS INC·Filed 2004·Granted Jul 15, 2008·29 cites·8 claims
- 2892US11673887B2N-acyl amino acid compounds and methods of usePLIANT THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·3 cites·68 claims
- 2992US8088793B2Certain chemical entities, compositions, and methodsQIAN XIANGPING·Filed 2008·Granted Jan 3, 2012·20 cites·74 claims
- 3092US7825120B2Certain substituted ((piperazin-1-ylmethyl)benzyl)ureasCYTOKINETICS INC·Filed 2006·Granted Nov 2, 2010·12 cites·3 claims
- 3192US7598248B2Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols, compositions thereof, and methods for their useCYTOKINETICS INC·Filed 2007·Granted Oct 6, 2009·17 cites·11 claims
- 3292US7491826B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2004·Granted Feb 17, 2009·27 cites·8 claims
- 3392US7332498B2Modulation of KSP kinesin activity with heterocyclic-fused pyrimidinone derivativesCYTOKINETICS INC·Filed 2005·Granted Feb 19, 2008·19 cites·10 claims
- 3491US7851484B2Certain chemical entities, compositions, and methodsCYTOKINETICS INC·Filed 2008·Granted Dec 14, 2010·14 cites·35 claims
- 3591US7582668B2Imidazoyl-benzamide anti-cancer agentsCYTOKINETICS INC·Filed 2006·Granted Sep 1, 2009·5 cites·6 claims
- 3691US7528137B2Compounds, compositions, and methodsCYTOKINETICS INC·Filed 2005·Granted May 5, 2009·19 cites·20 claims
- 3791US7208487B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2003·Granted Apr 24, 2007·39 cites·13 claims
- 3890US7038048B23H-pyridopyrimidin-4-one compounds, compositions, and methods of their useSMITHKLINE BEECHAM CORP·Filed 2003·Granted May 2, 2006·32 cites·20 claims
- 3989US8653081B2Certain chemical entities, compositions, and methodsCYTOKINETICS INC·Filed 2013·Granted Feb 18, 2014·4 cites·8 claims
- 4089US7956056B2Certain 1H-imidazo[4,5-B]pyrazin-2(3H)-ones and 1H-imidazo[4,5-B]pyrazin-2-ols, compositions thereof, and methods for their useCYTOKINETICS INC·Filed 2009·Granted Jun 7, 2011·10 cites·15 claims
- 4189US5859014APyrimidinedione, pyrimidinetrione, triazinedione and tetrahydroquinazolinedione derivatives as α1 -adrenergic receptor antagonistsSYNTEX INC·Filed 1996·Granted Jan 12, 1999·50 cites·21 claims
- 4289US5493030A5-substituted derivatives of mycophenolic acidSYNTEX INC·Filed 1994·Granted Feb 20, 1996·64 cites·3 claims
- 4388US11814367B2Inhibitors of glycogen synthase 1 (GYS1) and methods of use thereofMAZE THERAPEUTICS INC·Filed 2022·Granted Nov 14, 2023·4 cites·41 claims
- 4488US8410108B2Certain chemical entities, compositions and methodsMORGAN BRADLEY P·Filed 2010·Granted Apr 2, 2013·5 cites·9 claims
- 4588US7054755B2Interactive correlation of compound information and genomic informationICONIX PHARM INC·Filed 2001·Granted May 30, 2006·29 cites·14 claims
- 4688US6924376B2Compounds, compositions and methodsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Aug 2, 2005·22 cites·53 claims
- 4787US7910743B2Compounds, compositions and methodsCYTOKINETICS INC·Filed 2009·Granted Mar 22, 2011·4 cites·8 claims
- 4887US7166595B2Compounds, methods and compositionsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jan 23, 2007·25 cites·18 claims
- 4986US11976067B2APOL1 inhibitors and methods of useMAZE THERAPEUTICS INC·Filed 2023·Granted May 7, 2024·2 cites·159 claims
- 5086US11952376B2Substituted amino acids as integrin inhibitorsPLIANT THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·1 cites·172 claims
Showing the top 50 of 144 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David J. Morgans, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →